Co-Occurring Disorders in Substance Use Treatment: Integrated Assessment and Treatment Strategies for Dual Diagnosis Clients

CPD

Handouts

Speaker

Hayden Center, PHD, LPC Related seminars and products

---

Hayden Center, PhD, LPC, has been treating individuals and families who suffer from substance abuse disorders, including opioid use disorder, for over 25 years in a private practice setting. Dr. Center most recently served as the evaluator for the Center for Substance Abuse Prevention’s (CSAP) Southeast Center for the Application of Prevention Technologies (SECAPT) and the Border Center for the Application of Prevention Technologies (BCAPT).

Dr. Center served as a consultant to the Alabama Governor’s Office of Drug Abuse Policy for 10 years and has worked with numerous state and local agencies in the state of Alabama.

He has provided over 200 trainings on the topics of science-based prevention, evaluation, risk and protective factors, co-occurring disorders, and other mental health and substance abuse issues. His current interests are providing training and technical assistance to increase the usage and effectiveness of evidence-based treatments and approaches.

In addition to his private practice, Dr. Center has taught in university settings for over 28 years. He teaches graduate-level courses in theories of psychotherapy, advanced objective testing, psychopharmacology, and undergraduate courses in psychology at Auburn University in Montgomery, Alabama. He earned his PhD in counselor education and Master of Science in psychology at Auburn University in Montgomery, Alabama.

 

Speaker Disclosures:
Financial: Dr. Hayden Center maintains a private practice and has an employment relationship with the University of Phoenix. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Hayden Center is a member of the American Counseling Association.

Objectives

1. Evaluate the clinical implications of intoxication and withdrawal syndromes that can mimic mental health disorders.
2. Assess the differences and relative merits and limitations of abstinence and harm reduction models.
3. Utilize specific instruments to assess for mood, trauma, anxiety, ADHD, and substance use disorders.
4. Formulate treatment goals and objectives for patients with co-occurring disorders that are behavioural, measurable, meaningful and client specific.
5. Determine how high-risk situations influence level-of-care decision making in work with patients with co-occurring disorders.
6. Analyze strategies and current best practices to work people who have opioid use disorders and co-occurring mental health diagnoses.

Outline

Key Concepts

• Epidemiology of SUDs
• The differences between harm reduction and abstinence models
• The interplay of substance use and mental disorders
• Co-occurring disorders and the DSM-5® and ICD-10

High-Risk Areas for Misdiagnoses and Missed Diagnoses

• Prognostic implications of co-occurring disorders
• The co-occurring matrix - SUD/mental health combinations to look for
• Medical co-morbidities

Assessment and Screening Tools:
Uncover Mental Health Conditions and Their Relation to Substance Use

• The intake and pitfalls in obtaining the history
• How to assess for dangerousness to self or others
• Specific instruments to assess for mood, trauma, anxiety, ADHD
• Substance use screening tools
• Physical signs and symptoms of intoxication or withdrawal states
• Assessing readiness for change and motivation

How to Create Fully Integrated Treatment Plans for Clients with Co-Occurring Disorders

• Establishing the problem/need list
• Writing specific, realistic and measurable goals and objectives
• Identify and address emergent issues
• Wellness – nutrition, exercise, sleep
• How to approach level of care decisions
• How and when to access prescription monitoring databases
• Case studies

Evidence-Based Therapies and Strategies for Improved Outcomes

• Mindfulness for emotional regulation in recovery
• CBT techniques to establish new perspectives and behaviours
• DBT and dialectical abstinence interventions for non-judgmental problem solving
• Match motivational enhancement strategies to your clients’ stage of change
• Trauma-based therapies that target substance use disorders
• The Seeking Safety Model in dual diagnosis treatment
• Harm reduction and abstinence in the midst of the opioid overdose epidemic
• Research limitations and risks of psychotherapeutic approaches

Medication for Opioid Use Disorders/Medication Assisted Treatment (MOUD/MAT)

• Medication for opioid withdrawal
• MAT for alcohol withdrawal
• When MAT is not advised

Other Substance Specific Issues

• Sedative hypnotics
• Cocaine and other stimulants, including “Bath Salts”
• How cannabis impacts clients mental and physical health

Target Audience

• Counselors
• Addiction Counselors
• Social Workers
• Case Managers
• Marriage & Family Therapists
• Psychologists
• Nurses
• Other Mental Health Professionals